0001415889-22-012654.txt : 20221219
0001415889-22-012654.hdr.sgml : 20221219
20221219071423
ACCESSION NUMBER: 0001415889-22-012654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221216
FILED AS OF DATE: 20221219
DATE AS OF CHANGE: 20221219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Willard Stephen H
CENTRAL INDEX KEY: 0001325232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38302
FILM NUMBER: 221469600
MAIL ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001719406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822844431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 484-254-6134
MAIL ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp.
DATE OF NAME CHANGE: 20171012
4
1
form4-12192022_121215.xml
X0306
4
2022-12-16
0001719406
NRX Pharmaceuticals, Inc.
NRXP
0001325232
Willard Stephen H
C/O NRX PHARMACEUTICALS INC
1201 N. MARKET STREET, SUITE 111
WILMINGTON
DE
19801
true
true
false
false
CHIEF EXECUTIVE OFFICER
Common Stock, par value $0.001 per share
2022-12-16
4
P
0
50000
1.17
A
50000
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.20. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.
/s/ Stephen Willard
2022-12-18